Response to: ‘Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered’ by Elio Novembre, Mariannita Gelsomino, Lucia Liotti, Simona Barni, Francesca Mori, Mattia Giovannini, Carla Mastrorilli, Luca Pecoraro, Francesca Saretta, Riccardo Castagnoli, Stefania Arasi, Lucia Caminiti, Angela Klain, Michele Miraglia del Giudice

Subjects: “…Fatal anaphylaxis…”
Get full text

Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered by Francesca Nicolardi, Federica Corona, Laura Badina, Irene Berti, Egidio Barbi

Subjects: “…Fatal anaphylaxis…”
Get full text

Fatal food anaphylaxis in adults and children by Elio Novembre, Mariannita Gelsomino, Lucia Liotti, Simona Barni, Francesca Mori, Mattia Giovannini, Carla Mastrorilli, Luca Pecoraro, Francesca Saretta, Riccardo Castagnoli, Stefania Arasi, Lucia Caminiti, Angela Klain, Michele Miraglia del Giudice

Subjects: “…Fatal anaphylaxis…”
Get full text

Changes in anaphylaxis trends and characteristics in emergency department admissions in Türkiye: From 2015 to 2021 based on the Ministry of Health database by Elif Soyak Aytekin, MD, Seda Şirin, MD, Esra Kıratlı Nalbant, MD, Naim Ata, MD, Ahmet Sertçelik, MD, Mustafa Mahir Ülgü, MD, Şuayip Birinci, MD, Koray Harmancı, MD, Zülfikar Akelma, MD

Subjects: Get full text